Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bellone

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Immunology Today|July 1, 1993
Myasthenia gravis: recognition of a human autoantigen at the molecular levelM P Protti, A A Manfredi, R M Horton, et al.
European Journal of Immunology|November 1, 1994
In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cellsM Bellone, G Iezzi, A A Manfredi, et al.
Cancer Research|May 27, 1999
Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s)M A Imro, S Manici, V Russo, et al.
Human Gene Therapy|July 3, 1998
Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8+ cytotoxic T lymphocytes in vitroM A Imro, P Dellabona, S Manici, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1987
Thymopentine treatment improves clinical and immunological functions in aged subjects with chronic bronchitisD Pavoni, F Crosti, G F Ciboddo, et al.
Cancer Research|July 1, 1997
The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopesG Iezzi, L Rivolta, A Ronchetti, et al.
Cancer Research|June 11, 1999
Induction of therapeutic T-cell immunity by tumor targeting with soluble recombinant B7-immunoglobulin costimulatory moleculesM Moro, A M Gasparri, S Pagano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998
Processing of engulfed apoptotic bodies yields T cell epitopesM Bellone, G Iezzi, P Rovere, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Relevance of the tumor antigen in the validation of three vaccination strategies for melanomaM Bellone, D Cantarella, P Castiglioni, et al.
European Journal of Immunology|May 1, 1995
Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory responseF Cavallo, A Martin-Fontecha, M Bellone, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Immunology Today|July 1, 1993
Myasthenia gravis: recognition of a human autoantigen at the molecular levelM P Protti, A A Manfredi, R M Horton, et al.
European Journal of Immunology|November 1, 1994
In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cellsM Bellone, G Iezzi, A A Manfredi, et al.
Cancer Research|May 27, 1999
Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s)M A Imro, S Manici, V Russo, et al.
Human Gene Therapy|July 3, 1998
Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8+ cytotoxic T lymphocytes in vitroM A Imro, P Dellabona, S Manici, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1987
Thymopentine treatment improves clinical and immunological functions in aged subjects with chronic bronchitisD Pavoni, F Crosti, G F Ciboddo, et al.
Cancer Research|July 1, 1997
The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopesG Iezzi, L Rivolta, A Ronchetti, et al.
Cancer Research|June 11, 1999
Induction of therapeutic T-cell immunity by tumor targeting with soluble recombinant B7-immunoglobulin costimulatory moleculesM Moro, A M Gasparri, S Pagano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998
Processing of engulfed apoptotic bodies yields T cell epitopesM Bellone, G Iezzi, P Rovere, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Relevance of the tumor antigen in the validation of three vaccination strategies for melanomaM Bellone, D Cantarella, P Castiglioni, et al.
European Journal of Immunology|May 1, 1995
Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory responseF Cavallo, A Martin-Fontecha, M Bellone, et al.
Pageof 6